BDNF and pancreatic adenocarcinoma: It was worth noting that BDNF expression levels were remarkably decreased in PAAD patients aged older than 65 years, raising the possibility that elderly patients with pancreatic cancer might represent a heterogeneous subgroup with different molecular characteristics that require individualized antitumor therapy [43].